2021 Updates on Novel Therapies for HR-NMIBC: Nadofaragene Firadenovec, CG0070+/-Pembro, EG-70

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

NYU Langone

Adult & Family Medicine
Annual Focus on Men's Health 2023 Annual Focus on Men's Health 2022
Oncology and Hematology
8th Annual Breast Health Symposium Breast Cancer 101: Selected Topics in Breast Cancer Survivorship Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist Breast Cancer 101: New Direction and Updates in Prevention, Diagnosis, and Treatment Videos
Neurology & Neurosurgery
Advances in Neuromuscular Disorders 2024 Neuromodulation Symposium The Cutting Edges in Stroke and Neurology Update 2022: Case by Case Advances in Neuromuscular Disorders
Gastroenterology
Big Gut Seminars: Focus on Complex Inflammatory Bowel Disease Big Gut Seminars: Focus on Complex Esophageal Disease: Emerging Concepts and Controversies
Cardiovascular
Cardiac Amyloidosis: Diagnosis and Novel Therapeutics in 2024 Advanced Heart Failure Cases and Controversies Invasive Cardiology Update for Practicing Health Care Professionals 2023 Unique Topics in Adult Congenital Heart Disease Management Decisions in Hypertrophic Cardiomyopathy Imaging in Adult Congenital Heart Disease Cases and Controversies in Heart Failure 2022 Venous Thrombosis Update 2022
Pulmonology
Chronic Care Management – Achievements, Challenges, and Future Endeavors from Pediatrics to Adults Asthma, Airways and the Environment Moving Forward with Sarcoidosis Controversial Topics in Sarcoidosis Multidisciplinary Evaluation and Individualized Treatment of Sleep Disorders
Dermatology
44th Annual Advances in Dermatology 43rd Annual Advances in Dermatology Pediatric Dermatology for the General Practitioner
Endocrinology
Rheumatology
NYU Langone Seminar in Advanced Rheumatology
Events

Playback speed

10 seconds

2021 Updates on Novel Therapies for HR-NMIBC: Nadofaragene Firadenovec, CG0070+/-Pembro, EG-70

By Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist FEATURING Gary Steinberg

22 views

May 23, 2021

Comments 0

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Operationalizing Bladder Cancer Clinic

NYU Langone

N. Shore

34 views

Treatment of Locally Advanced Urothelial Cell Carcinoma: Neoadjuvant…

NYU Langone

N. Hahn

435 views

NYU Langone Updates on Bladder Preservation for MIBC

NYU Langone

V. Adorno Febles

28 views

NYU Langone Updates on Upper Tract Urothelial Cancer

NYU Langone

A. Corcoran

72 views

Complications of Radical Cystectomy: Management Strategies

NYU Langone

M. Metcalf

23 views

Radical Cystectomy: Open vs. Robotic Approaches

NYU Langone

M. Gupta

16 views

Immune CPI in Combination With Other IO & IO Delivery Systems

NYU Langone

G. Steinberg

28 views

Checkpoint Inhibitors in the Treatment of NMIBC

NYU Langone

J. Meeks

35 views

Intravesical BCG: State of the Art 2022

NYU Langone

A. Kamat

49 views

Treatment/Surveillance Algorithms/AUA NMIBC Guidelines

NYU Langone

L. Barlow

64 views

Managing High-Risk NMIBC: Options When BCG Is Not Effective

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

G. Steinberg

45 views